Nyhet -

A winning team for In Vivo Research Services

Based in Medicon Village, IVRS (In Vivo Research Services) is a preclinical CRO which provides innovating drug validation studies both in vitro and in vivo allowing to accelerate the drug development process for unmet needs related to severe human diseases.

IVRS specialises in providing 3D-images with the aim to characterise disease progression; follow the therapeutic effect throughout the complete experimental time frame; the circulation and spreading of candidate drug in the whole body and targeted organs, as well as monitor pharmacokinetic/pharmacodynamic of probe distribution in vivo.

Which imaging technology is needed?

An important question to IVRS is; which imaging technology is needed to accelerate the preclinical phase into clinical? IVRS CEO Ramin Massoumi explains:

“Our mission is to bridge the gap between preclinical and clinical studies. We make it possible to follow disease progression and treatment over time by offering whole body imaging 3D. In addition, our technology saves time and resources in any preclinical studies and data collection, as each step of the disease progression is being closely monitored by visual effect”.

3D body imaging

IVRS’ expertise enables the team to provide services within: Disease models, Diagnostics, and Treatments. The platform provided by IVRS help guide decision making for clinical development stage by performing visual and quantitative studies as well as the inhibitory effect of potential therapeutic effects in living animals.

Using the most advanced and sensitive instrument on the world market, IVRS can provide in vivo optical imaging of cells, antibodies, small molecules and nanoparticles to assist studies for their clients.

With body imaging in 3D, IVRS can offer clients the opportunity to explore further the effects of treatment in controlled preclinical settings as well as allowing clients to save time by collecting data at each step of the experiment whilst reducing the cost by monitoring the same animal. It also allows them to follow the disease progression in real time from the start and identify the critical time in vivo.

Presence in Medicon Village

With a presence in Medicon Village as well as being a member of Science Exchange and scientist.com, and selected as the industrial winner of 2022 within Life Science companies in Sweden, IVRS continues to create and look for business opportunities with R&D organisations who have an immediate need for advanced imaging services in vivo.

Relaterade länkar

Ämnen

  • Ekonomi, finans

Kategorier

  • medicon valley life science

Regioner

  • Skåne

Kontakter

Relaterad media

Relaterat innehåll

  • The uniqueness of Medicon Valley Alliance

    Medicon Valley Alliance (MVA) is a non-profit membership organisation in the Danish-Swedish life science cluster Medicon Valley. They also have the distinction of being the only bi-national cluster region in the Nordics.
    All cluster formations within Life Science collaborate with other actors nationally and internationally, but MVA has built an entire life science cluster across two leading lif

  • The splendour of tolerogenic cell therapies

    The biotech company Idogen develops tolerogenic cell therapies to prevent biological drugs, transplanted organs or the body’s own cells or tissue from being attacked by the patient’s immune system.
    Idogen was founded 2008 in Lund, but is today a public company listed on the Nasdaq First North Growth Market. The company has now entered into a very exciting phase where it’s first clinical trial,

  • The Peritus Clinic offers the fastest treatment for prostate cancer

    The Peritus Clinic is located in Lund, to be more precise, on Scheelevägen 8, adjacent to the Medicon Village science park. Patients with different kinds of prostate diseases are welcomed to a modern, world-class hospital with four operating theaters, one of which is equipped with the latest DaVinci robotic surgery platform.
    Peritus’ goal is to establish a clinic at the forefront that gathers

Fyll i din epostadress för att följa Affärstidningen Näringsliv

När du väljer att skapa ett konto och följa ett nyhetsrum kommer dina personuppgifter behandlas av oss och av ägaren av nyhetsrummet för att du ska kunna motta nyheter och uppdateringar enligt dina bevakningsinställningar.

För att läsa mer om detta, var vänlig läs vår Integritetspolicy som berör vår behandling av dina personuppgifter, och Integritetspolicy för Contacts som berör behandlingen av dina personuppgifter från ägaren av nyhetsrummet du följer.

Vänligen notera att våra Användarvillkor gäller alla våra tjänster.

Du kan dra tillbaka ditt samtycke när som helst genom att avregistrera dig eller genom att ta bort ditt konto.
Kolla din inkorg

Mejl skickat till __email__. Klicka på länken i mejlet för att följa Affärstidningen Näringsliv.

Okej